Downstream to cAMP signaling, intracellular activation of protein kinase A (PKA) and cAMP-regulated guanine nucleotide exchange factor (cAMP-GEFII or Epac2) are considered the main pathways mediating the metabolic effects of GLP-1 (Figure 1)
doi: 10.1210/jcem-63-2-492 2 GasbjergLSHelstedMMHartmannBJensenMHGabeMBNSparre-UlrichAHet al
These medications mimic a natural hormone that helps regulate appetite, slow digestion, and support healthier blood sugar patterns
When your stomach empties more slowly, hunger returns much later
In order for GLP-1s to gain FDA approval for this use, they must go through two well-designed (large, randomized, double-blind, placebo-controlled) phase 3 clinical trials that, ideally, run for 6 to 12 months
Importance of Medical Supervision Because GLP-1 affects multiple systems, careful monitoring by a healthcare provider is essential